Apeximmune

Developer of novel biologics designed to modulate the immune system. The company's platform combines bioinformatics with biological assays to enable the identification of novel immune-modulating targe...

Healthcare

South San Francisco, CA, United States

Founded 2016

6 employees

Website

Valuation

$62.7M

Market implied

Share Price

N/A

Total Raised

$32.8M

Last Round

N/A

Investors

+9 other investors

View all 9 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Apeximmune's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required